openPR Logo
Press release

Exosome Diagnostic and Therapeutic Market: Growth & Revenue Opportunities by Top Key Players Exosome Diagnostics Inc. (U.S.), NanoSomix Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Malvern Instruments Ltd. (U.K,) and others

11-06-2018 11:38 AM CET | Health & Medicine

Press release from: Allied Market Research

Exosome Diagnostic and Therapeutic Market

Exosome Diagnostic and Therapeutic Market

The key players of the world exosome diagnostic and therapeutic market are employing novel concepts and ideas to improve exosome isolation techniques and the current set of products, and also enhance their profitability so as to gain a competitive edge over the other market players. Therefore, the key players have adopted product launch as the key developmental strategy to keep pace with the changes in demands for end users. Furthermore, several companies have launched technologically advanced exosome research instrument and tools to strengthen their market position.

Exosome Diagnostic and Therapeutic Market is projected to gather $367 million by 2022, registering a CAGR of 37.8% during the period 2016-2022. Diagnostic application segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America accounted for more than half of the world exosome diagnostic and therapeutic market share in 2015.

Increase in incidence and prevalence of cancer, growth in investments and initiatives implemented by the government and non-government associations around the world are the factors that majorly drive the growth of this market. The technological advancements for easy exosome isolation and advanced exosome based products for new applications also support the growth of the world exosome diagnostic and therapeutic market. However, stringent government regulations for the product approval, and low awareness about the applications of exosome in developing countries restrict the market growth.

In 2015, the diagnostic application segment accounted for around two-thirds share of the overall exosome diagnostic and therapeutic market. Increase in demand for exosome as a biomarker in the diagnosis of cancer, and increase in prevalence of cancer with rise in geriatric population and changes in lifestyle are the major factors that attribute to the rise in growth of this market

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/1723?utm_source=sy-Openpr


The key players in the exosome diagnostic and therapeutic market are highly focused on expanding their business operations in the fast-growing emerging countries with new product launches as the preferred strategy.

The key players profiled in this report include
• Aethlon Medical, Inc. (U.S.)
• Exosome Diagnostics Inc. (U.S.)
• NanoSomix Inc. (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Malvern Instruments Ltd. (U.K,)
• System Biosciences Inc. (U.S.)
• NX Pharmagen (U.S.)
• Sistemic Inc. (U.K.)
• Capricor Therapeutics (U.S.)
• Exiqon A/S (Denmark).

The instrument segment held the leading position with over 50% market share of the world exosome diagnostic and therapeutic market in 2015, owing to their frequent use in healthcare facilities for the isolation of exosome and research procedures. However, the software segment is estimated to register CAGR of 38.3% during the forecast period owing to innovative and advanced applications of exosome-based software for the data analysis and base pair estimations; and increase in implementation in research laboratories.

Among the end users, the cancer institute segment held around two-fifths share of the world exosome diagnostic and therapeutic market in 2015. This segment is expected to maintain its leading position in the overall market throughout the analysis period, primarily because of increase in focus on the use of exosomes for cancer management and increase in government support in the form of funding for the research on development of innovative exosome based diagnostic & therapeutic techniques.

North America and Europe together accounted for more than three-fourths share of overall market in 2015, and is expected to maintain this lead throughout the forecast period. The growth in the exosome diagnostic and therapeutic market in these regions attributes to the technological advancement in the isolation of exosomes, innovative and advanced applications of exosome-based products, and geriatric population coupled with increase in incidence of diseases such as cancer and cardiovascular diseases.

However, Asia-Pacific is projected to be the fastest-growing region, registering a CAGR of 38.8% during the analysis period. This is mainly due to the increase in awareness of innovative and advanced applications of exosome-based diagnostic and therapeutic products. In addition, increase in research outsourcing from emerging markets, improvement of healthcare infrastructures, and increase in expenditures in the emerging markets (such as India and China) have boosted the market growth.

For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/1723?utm_source=sy-Openpr


Key findings of Exosome Diagnostic and Therapeutic Market:
• In 2015, diagnostic application was the leading segment of overall exosome diagnostic and therapeutic market revenue, and is projected to grow at a CAGR of 41.5% during the forecast period.
• Software segment is expected to grow at a remarkable CAGR of 38.3%, owing to increased demand in the life science research studies.
• North America accounted for over half of the world exosome diagnostic and therapeutic market in 2015.
• The cancer institute segment is projected to be the largest revenue-generating end user segment in the world exosome diagnostic and therapeutic market during the forecast period.
• Japan alone is the major shareholder in the Asia-Pacific region accounting for about two-fifth share of the Asia-Pacific exosome diagnostic and therapeutic market.

Access Full Summery @ https://www.alliedmarketresearch.com/press-release/exosome-diagnostic-and-therapeutic-market.html?utm_source=sy-Openpr

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Exosome Diagnostic and Therapeutic Market: Growth & Revenue Opportunities by Top Key Players Exosome Diagnostics Inc. (U.S.), NanoSomix Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Malvern Instruments Ltd. (U.K,) and others here

News-ID: 1355001 • Views:

More Releases from Allied Market Research

SOC as a Service Market Share Reach USD 9.9 Billion by 2031
SOC as a Service Market Share Reach USD 9.9 Billion by 2031
Allied Market Research published a new report, titled, " The SOC as a Service Market Share Reach USD 9.9 Billion by 2031." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps
A Look at the Microbial Incubators Market | Is Projected to Reach $508.5 Million By 2032
A Look at the Microbial Incubators Market | Is Projected to Reach $508.5 Million …
Microbial incubators, those unsung heroes of countless laboratories, are the controlled environments where the tiny powerhouses of life - microbes - flourish. From culturing bacteria for medical research to fostering yeast strains for beer production, these incubators are vital tools across various scientific disciplines. The global microbial incubators market size was valued at $315.2 million in 2022, and is projected to reach $508.5 million by 2032, growing at a CAGR
Market Growth of Automotive RADAR Industry : $4.08 Billion in 2020, Projected to Reach $10.06 Billion by 2028, CAGR of 12.6% (2021-2028)
Market Growth of Automotive RADAR Industry : $4.08 Billion in 2020, Projected to …
According to a recent report published by Allied Market Research, titled, "Automotive RADAR Market Size, Share, Competitive Landscape and Trend Analysis Report by Application, Frequency, Range and Vehicle Type Global Opportunity Analysis and Industry Forecast, 2021-2028". 𝐀𝐮𝐭𝐨𝐦𝐨𝐭𝐢𝐯𝐞 𝐑𝐀𝐃𝐀𝐑 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐚𝐭𝐢𝐬𝐭𝐢𝐜𝐬 𝟐𝟎𝟐𝟏-𝟐𝟎𝟐𝟖 : The global automotive RADAR market was valued at $4.08 billion in 2020, and is projected to reach $10.06 billion by 2028, registering a CAGR of 12.6%. 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬
Off-Road Vehicle Market : $12.37 Billion in 2020, Projected to Reach $22.62 Billion by 2030, CAGR of 7.3% (2021-2030)
Off-Road Vehicle Market : $12.37 Billion in 2020, Projected to Reach $22.62 Bill …
According to a recent report published by Allied Market Research, titled, "Off-Road Vehicle Market Size, Share, Competitive Landscape and Trend Analysis Report by Displacement, Vehicle Type, End Use Vertical : Global Opportunity Analysis and Industry Forecast, 2021-2030." 𝐎𝐟𝐟-𝐑𝐨𝐚𝐝 𝐕𝐞𝐡𝐢𝐜𝐥𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐚𝐭𝐢𝐬𝐭𝐢𝐜𝐬 𝟐𝟎𝟐𝟏-𝟐𝟎𝟑𝟎 : The global off-road vehicle market was valued at $12.37 billion in 2020, and is projected to reach $22.62 billion by 2030, registering a CAGR of 7.3% from 2021

All 5 Releases


More Releases for Diagnostic

Tenet Diagnostic: Reshaping the Diagnostic Industry in India
Tenet Diagnostic was incorporated in 2018 with an aim to establish high-quality diagnostics laboratories across India. The company caters to both B2B and B2C. They have seven different verticals namely: End Customer (B2C), Lab to Lab Test Outsourcing, Corporates and Institutions, large management (Hospitals, Medical Colleges, and other healthcare institutions), Clinical Trials, Home Sample Collection, and Government PPP Projects. Tenet Diagnostics got its NABL certification in the fastest time and is
Global Tissue Diagnostic Market 2020 Business Strategies – Roche Diagnostic, A …
The Zion Market Research added a new report “Tissue Diagnostic Market by Product Type (Consumables and Instruments), by Technology (Immunohistochemistry (IHC), in Situ Hybridization (ISH), Digital Pathology and Workflow Management, and Special Staining), by Diseases (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC), and Others), and by End-users (Hospitals, Research Laboratories, Ambulatory Surgical Centers, Diagnostic Centers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017
Diagnostic Imaging Services Market 2019 Analyzed by Top Key Players PH3 Healthca …
Big Market Research has added a report, titled, "Diagnostic Imaging Services" The report not only provides a comprehensive analysis of market overview and dynamics for the historical period, 2019-2026, but also offers global and regional forecasts on market value, volume production, and consumption during the future period, 2019-2026. The report also analyzes the key market players, especially the distributors, along with the industrial chain structure. The evolution of market trends
POC Cardiovascular Diagnostic Market Report 2018: Segmentation by Product (Diagn …
Global POC Cardiovascular Diagnostic market research report provides company profile for F. Hoffmann-La Roche, Siemens, Abbott, Biomerieux, Danaher and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation on
Cervical Dysplasia Diagnostic Market - by Diagnostic, and End Users
Cervical infection is major risk factor for progression of HPV. Currently, conventional Pap smear test or HPV test are the only test available for screening cervical infection, which in turn propels the demand for development of DNA-based molecular testing to detect human papillomavirus for diagnosis of cervical cancer. For instance, in 2016, Becton, Dickinson and Company received pre-diagnostic market approval from FDA for its Onclarity HPV assay, type of HPV
Diagnostic Imaging Services Market Trending Technologies and Company Overview 20 …
Diagnostic Imaging Services market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the